Načítá se...
Targets for Neuroprotection in Parkinson’s Disease
Current therapies for Parkinson’s disease significantly improve the quality of life for patients suffering from this neurodegenerative disease, yet none of the current therapies has been convincingly shown to slow or prevent the progression of disease. Much has been learned about the pathophysiology...
Uloženo v:
| Hlavní autoři: | , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2008
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2740981/ https://ncbi.nlm.nih.gov/pubmed/18930814 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbadis.2008.09.009 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|